Why the study?
Do cardiac papillary fibroelastomas harbor KRAS mutations indicating a neoplastic etiology?
Do cardiac papillary fibroelastomas harbor KRAS mutations indicating a neoplastic etiology?
A significant proportion of cardiac papillary fibroelastomas harbor KRAS mutations, providing evidence that they are genuine neoplastic tumors driven by oncogenic mutations.
No takes yet. Share an insight, caveat, or question.
Supports neoplastic etiology for cardiac papillary fibroelastomas; leaves open diagnostic or therapeutic implications pending validation.
Wittersheim et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: